CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 77 filers reported holding CYTOSORBENTS CORP in Q2 2018. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $26,000 | -7.1% | 3,500 | 0.0% | 0.01% | -18.2% |
| Q4 2018 | $28,000 | +16.7% | 3,500 | +75.0% | 0.01% | +10.0% |
| Q3 2018 | $24,000 | +118.2% | 2,000 | +100.0% | 0.01% | +100.0% |
| Q2 2018 | $11,000 | +57.1% | 1,000 | 0.0% | 0.01% | +66.7% |
| Q1 2018 | $7,000 | 0.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $7,000 | +16.7% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $6,000 | +50.0% | 1,000 | 0.0% | 0.00% | +50.0% |
| Q2 2017 | $4,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 249,430 | $2,015,000 | 1.24% |
| Manatuck Hill Partners, LLC | 194,100 | $1,568,000 | 0.81% |
| Skylands Capital, LLC | 495,850 | $4,006,000 | 0.66% |
| EAM Global Investors LLC | 78,027 | $630,000 | 0.34% |
| EAM Investors, LLC | 107,531 | $869,000 | 0.24% |
| Granahan Investment Management | 278,170 | $2,248,000 | 0.16% |
| Wealthcare Advisory Partners LLC | 62,079 | $502,000 | 0.10% |
| Avenir Corp | 76,390 | $617,000 | 0.08% |
| Crow Point Partners, LLC | 48,576 | $380,000 | 0.07% |
| Kalos Management, Inc. | 14,700 | $120,000 | 0.06% |